Associations between prostate-specific antigen response as well as circulating tumour cell decline and higher baseline androgen levels were demonstrated. »
03/06/14
No clinical variables (including prior response to abiraterone) were found to associate significantly with confirmed PSA response to enzalutamide. »
05/15/14
Totally dysregulated molecular events at the immunological synapse in glioma are restored back to normal levels with the administration of T11TS. »
01/10/14